GOFEN & GLOSSBERG LLC /IL/ - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 2 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOFEN & GLOSSBERG LLC /IL/ ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2015$86,000
+160.6%
25,0000.0%0.00%
+300.0%
Q2 2015$33,000
+57.1%
25,0000.0%0.00%0.0%
Q1 2015$21,000
+110.0%
25,0000.0%0.00%
Q4 2014$10,000
-90.8%
25,0000.0%0.00%
-100.0%
Q3 2014$109,000
-12.1%
25,0000.0%0.01%0.0%
Q2 2014$124,000
-8.8%
25,0000.0%0.01%
-16.7%
Q1 2014$136,000
-10.5%
25,0000.0%0.01%
-14.3%
Q4 2013$152,000
-8.4%
25,0000.0%0.01%
-22.2%
Q3 2013$166,000
+30.7%
25,0000.0%0.01%
+28.6%
Q2 2013$127,00025,0000.01%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Advisors Asset Management, Inc. 1,148,396$8,912,0000.12%
WEDBUSH SECURITIES INC 207,526$174,0000.03%
MARATHON CAPITAL MANAGEMENT 55,000$46,0000.02%
Brown Advisory Securities, LLC 28,000$24,0000.01%
Virtu KCG Holdings LLC 30,635$26,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$21,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 20,200$8,0000.00%
BANK OF MONTREAL /CAN/ 3,075$3,0000.00%
Citadel Advisors 32,075$27,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,800$9,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders